RO7034067, Evrysdi 0.75 mg/mL powder for oral solution
BN44619
Phase 2 small_molecule active
Quick answer
RO7034067, Evrysdi 0.75 mg/mL powder for oral solution for Spinal Muscular Atrophy (SMA) is a Phase 2 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Spinal Muscular Atrophy (SMA)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active